Companies / MAIA Biotechnology, Inc.

MAIA Biotechnology, Inc.

NYSE: MAIACIK 1878313CHICAGO, IL

Financials · FY2024

Revenue$0
Net income$-22.40M
Total debt$0
Cash$0
Diluted EPS$-0.70
Shares outstanding60.8M

Ownership

60.8M shares outstanding · as of Aug 10, 2026
2.4%Insiders
Ownership
Insiders2.37%1,444,178
Institutions5.10%3,102,779
Public float92.52%56,278,887

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Smith StanDirector
2.37%1,444,178
Theagene Jean-ManasseFormerDirector

Institutional holders 28

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Sep 19, 2022Smith Stan
Director
BuyCommon Stock$10.0K+3K
+0.19%
1,424,178
2.34% of shares
low
May 1, 2024Smith Stan
Director
GiftCommon Stock$0+20K
+1.40%
1,444,178
2.37% of shares
low
Dec 31, 2025Theagene Jean-Manasse
Director
GrantOptions+24K
24,060
0.04% of shares
low
Dec 31, 2025Smith Stan
Director
GrantOptions+29K
29,216
0.05% of shares
low
Dec 31, 2025Luput Cristian
Director
GrantOptions+25K
25,206
0.04% of shares
low
Dec 31, 2025Louie Ngar Yee
Director
GrantOptions+30K
29,789
0.05% of shares
low
Dec 31, 2025Guerrero Ramiro
Director
GrantOptions+24K
24,060
0.04% of shares
low
Dec 31, 2025Chaouki Steven M
Director
GrantOptions+25K
24,633
0.04% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MAIACommon StockEquity552641102BBG0113Q7J88